7-h

Hepta-histidine is a novel inhibitor of Tau aggregation against Tau-related neurodegenerative diseases including Alzheimer's disease (AD).

CGP77675 (ZINC1488120) is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and autophosphorylation of purified Src. CGP77675 exhibits anticancer activity.

2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimid is a chemical agent.

7H-pyrrolo[2,3-d]pyrimidine ,with CAS No. 271-70-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 7H-pyrrolo[2,3-d]pyrimidine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

2-Methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol ,with CAS No. 67831-83-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-Methylsulfanyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

3-Bromo-5H,6H,7H,8H-imidazo[1,2-a]pyrazine, with CAS No. 954239-19-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 3-Bromo-5H,6H,7H,8H-imidazo[1,2-a]pyrazine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

tert-butyl 4-Chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H) ,with CAS No. 1053657-15-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. tert-butyl 4-Chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H) provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

{4H,6H,7H-thieno[3,2-c]pyran-4-yl}methanamine hydrochloride, with CAS No. 57153-42-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. {4H,6H,7H-thieno[3,2-c]pyran-4-yl}methanamine hydrochloride provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

INCB032304 is an important pharmaceutical intermediate. It can be used in the preparation of Ruxolitinib phosphate (I008849), a janus kinase inhibitor, and in the preparation of Barretinib.

Tinoridine is a quinoline derivative analog that acts by inhibiting the production of cyclooxygenase-2 (COX-2). It has anti-inflammatory, anti-allergic and anticoagulant activities.

7-benzyl-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a inhibitor of Hepatitis C Virus(HCV).

7H-Pyrrolo[2,3-c]pyridin-7-one,1,6-dihydro-(9CI), with CAS No. 259684-36-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 7H-Pyrrolo[2,3-c]pyridin-7-one,1,6-dihydro-(9CI) provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

2-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine ,with CAS No. 1060815-90-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine ,with CAS No. 3680-69-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid ,with CAS No. 186519-92-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylic acid provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

2-Acetyl-3-methyl-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridine-4,6-dione ,with CAS No. 870692-82-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-Acetyl-3-methyl-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridine-4,6-dione provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde ,with CAS No. 1060815-89-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 7H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-Chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one ,with CAS No. 346599-63-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Chloro-5H-pyrrolo[2,3-d]pyrimidin-6(7H)-one provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

4-Bromo-7H-pyrrolo[2,3-d]pyrimidine ,with CAS No. 889939-42-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Bromo-7H-pyrrolo[2,3-d]pyrimidine provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

AHR agonist 3 is an agent with therapeutic activity.

8-Aminoadenine (7H-purine-6,8-diamine) is a ligand for Adenine Receptor with Ki of 0.0341 μM.

(Rac)-Byakangelicin (7H-Furo[3,2-g][1]benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-) is an antineoplastic agent.

Purine (7H-Imidazo(4,5-d)pyrimidine) is a heterocyclic aromatic organic compound, consisting of a pyrimidine ring fused to an imidazole ring. Two of the bases in nucleic acids, adenine and guanine, are purines. Purines from food (or from tissue turnover) are metabolised by several enzymes, including xanthine oxidase, into uric acid. High levels of uric acid can predispose to gout when the acid crystalises in joints; this phenomenon only happens in humans and some animal species (e.g. dogs) that lack an intrinsic uricase enzyme that can further degrade uric acid.

12-oxo-N-[1-(propan-2-yl)piperidin-4-yl]-6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide available as a molecular structural unit, it is used in the synthesis of various compounds.